You can buy or sell COCP and other stocks, options, ETFs, and crypto commission-free!
Cocrystal Pharma, Inc. Common Stock, also called Cocrystal Pharma, is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. Read More It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA. The listed name for COCP is Cocrystal Pharma, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 7, Pre-Market